Second, animal studies have demonstrated that overexpression of Trpc6 leads to hypertrophic cardiomyopathy and heart failure in mice (40) and genetic deletion or inhibition of Trpc6 reduces pressure overload in models of HF (41). Here, TRPC6 is linked to hypertrophic cardiomyopathy.